Silicos expands biology lab and announces move to new facilities
Drug development biotech further extends its computational fragment based drug design efforts with increased biology lab
“Our biology lab will enable Silicos to rapidly confirm the results of our computational fragment based drug discovery efforts, thereby shortening the cycle and further speed up the pace of lead discovery, which is the key of our business model”, commented Hans De Winter, Silicos’ CSO.
Silicos is at present leasing lab space from the University of Hasselt in Belgium. As part of a move to further extending its capabilities the company will move into new accommodation on the same research park that combines offices, computer facilities and lab space.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.